Expansion to create 50 new high-skilled jobs in AI and reinforce Sanofi’s long-term commitment to OntarioInvest Ontario Fund to contribute a conditional grant of up to $5 millionPartnership with the Province of Ontario and Toronto’s strong AI talent pool key drivers in site selection

TORONTO, May 4, 2026 /CNW/ – Sanofi, an R&D-driven, AI-powered biopharma company and Canada’s largest biopharma manufacturer, is expanding its global Artificial Intelligence (AI) Centre of Excellence in Toronto, deepening its investment in Ontario and growing AI talent to develop and manufacture life-changing medicines and vaccines faster than ever before.

The $294 million expansion will create 50 new high-skilled jobs in artificial intelligence and machine learning, building on the more than 150 roles created in just four years since establishing the AI Centre of Excellence (COE) in 2022 in downtown Toronto. These new roles will lead the design and deployment of advanced AI tools used throughout Sanofi’s global research, manufacturing and business operations, accelerating the delivery of breakthrough medicines and vaccines to patients worldwide.

The expansion will be supported by a conditional grant of up to $5 million from the Invest Ontario Fund, which recognizes Sanofi’s sustainable, long-term commitment to Ontario’s innovation ecosystem, and reinforces the province’s position as a global leader in AI-powered healthcare innovation.

“With local biopharma expertise and a world-class AI talent pool in Toronto, we are developing made-in-Canada solutions that are being scaled to operations across the globe,” said Dimitrije Jankovic, Sanofi’s Global Head of Digital Strategy and Operations. “We appreciate the partnership with the Province of Ontario – their support will help us continue our growth here and create tremendous opportunities for AI talent to join us in transforming healthcare.”

Through this expansion, Sanofi is extending new global AI mandates and long-term leadership roles to Ontario, demonstrating growing international confidence in the province’s ability to support complex, large-scale innovation within global organizations.

“Our government is proud to welcome this exciting new investment and to support Sanofi as they continue expanding their footprint here in Ontario,” said Premier Doug Ford. “Today’s announcement is a clear demonstration of Sanofi’s confidence in our world-class STEM workers and ensures they will continue to play a central role as we make Ontario a global hub for the development of cutting-edge technologies.”

“Sanofi’s investment is a testament to Ontario’s leadership in the AI and life sciences sectors, reinforcing our reputation as the best place to innovate, scale, and succeed,” said Vic Fedeli, Minister of Economic Development, Job Creation and Trade. “We look forward to seeing Sanofi continue to grow in the province, creating good-paying jobs for our workers and producing essential medicines and vaccines for Canada and the world.”

“Sanofi’s Artificial Intelligence Centre of Excellence expansion advances technologies that can transform patient outcomes and enhance our health-care system. This investment will create long–term economic opportunity while delivering tangible health benefits for families across the province and the country, including support for life sciences work that enables Sanofi to protect millions of Canadians from infectious disease through vaccine production, alongside other innovative research and development initiatives.” — Sylvia Jones, Minister of Health

“Toronto is proud to welcome this new investment from Sanofi. Our world-class AI talent, strong life sciences sector, and dynamic innovation community make Toronto a natural destination for companies that want to grow and lead. We look forward to seeing Sanofi continue to expand and contribute to the strength of our city and to better health outcomes for people here and around the world.” — Mayor Olivia Chow

About Sanofi’s Global AI Center of Excellence

The Toronto AI COE serves as a strategic innovation engine for Sanofi. With co-location of data, AI, scientific, manufacturing and product teams in Toronto, teams are uniquely positioned to work across the full life sciences value chain to enable faster iteration of solutions, which can be scaled across 90+ countries, delivering real-world impact for patients globally.

“AI is woven into the fabric of how we discover, develop, produce, launch, and support innovative therapies at Sanofi. Our Toronto AI COE exemplifies how we’re harnessing artificial intelligence, accelerating our mission to halve the time from discovery to delivery of innovative treatments,” said Emmanuel Frenehard, Sanofi’s Chief Digital Officer. “Our investments in Canada are building the foundation for the next generation of breakthrough medicines and vaccines.”

The investment announced today will create permanent Ontario-based capability, with 50 new roles by 2028, and support the expansion of technology partnerships as well as the expansion of the COE’s facilities in downtown Toronto. Additionally, it will enable the growth of Sanofi’s internship program, which currently recruits 30+ students annually from Ontario universities, with strong conversion to full-time employment.

This investment aligns with Sanofi’s broader commitment to Canada, including over $2 billion in new infrastructure investments by 2028 across its 52-acre Toronto campus. Through direct and spillover effects, the company supported 12,000 jobs across Canada in 2024 and contributed nearly $2.02 billion to Canada’s GDP, with exports reaching 60 countries around the globe.

About Sanofi

Sanofi is an R&D driven, AI-powered biopharma company committed to improving people’s lives and delivering compelling growth. We apply our deep understanding of the immune system to invent medicines and vaccines that treat and protect millions of people around the world, with an innovative pipeline that could benefit millions more.

Sanofi is the largest biopharma manufacturer in Canada, investing, innovating and operating across the full life sciences value chain. We are 2,000+ employees strong, invest 20% of our revenue annually in biopharma research, and are on track to deliver over $2 billion in new infrastructure investments by 2028. Sanofi is committed to our community and is working with partners to foster a long-term sustainable ecosystem and build a healthier Canada.

SOURCE SANOFI

NOVI, Mich., May 4, 2026 /PRNewswire/ — Hino Trucks today introduced the all-new Le Series battery electric vehicle (BEV) at ACT Expo 2026, reinforcing the company’s commitment to reducing environmental impact across its product portfolio. The Le Series is available in both 25,950 lbs. (L6e) and 33,000 lbs. (L7e) GVWR configurations.

The introduction of the Le Series reflects Hino’s continued focus on supporting customers as they work to improve their environmental footprint, while maintaining the performance, durability, and ownership experience fleets expect.

“Introducing the Le Series is an important step in our efforts to reduce environmental impact and support our customers’ sustainability goals,” said Rodney Shaffer, Vice President, National Accounts & Zero Emission Vehicles of Hino Trucks. “We’ve focused on delivering a solution that builds on our proven platform and is well-suited for the applications where electric vehicles make the most sense, helping fleets take practical and meaningful steps toward lower emissions.”

Energy is supplied by the Hexagon Purus ProPack™ Battery System with Panasonic Energy lithium-ion battery cells rated at 269 kWh and up to 750 volts. DC fast charging (CCS Type 1 / 120 kW) enables 0–80 percent state-of-charge in approximately 1.8 hours. Powered by Accelera’s Integrated e-Axle 14Xe Gen 4.5, the Le Series delivers 260 kW / 348 hp of peak power and 180 kW / 241 hp continuous power through an integrated two-speed automatic transmission and axle.

The advanced electrical system supports high energy efficiency and optimized range, helping fleets improve operational efficiency while reducing emissions. Programmable regenerative braking and improved weight distribution further enhance overall vehicle performance.

Drivers benefit from smooth, responsive electric torque and quiet operation, contributing to reduced fatigue and improved driving comfort. For body builders, the clear back-of-cab design simplifies upfitting across a range of applications.

The Le Series also comes standard with an automatic emergency braking system and lane departure warning system.

Production is scheduled to begin in Q3 2026, supporting Hino’s broader efforts to deliver practical solutions that align with evolving environmental standards and customer needs.

About Hino Trucks: Hino Trucks, manufactures, distributes, and services a lineup of Class 6-8 commercial trucks in the United States. Hino Trucks offers a product lineup focused on low total cost of ownership, proven reliability, maneuverability, and a comprehensive bundle of standard features. Hino is committed to supporting customers with practical solutions that help reduce environmental impact while meeting the demands of real-world applications. Headquartered in Novi, Michigan, Hino has a nationwide dealer network committed to delivering the ultimate ownership experience.

View original content to download multimedia:https://www.prnewswire.com/news-releases/hino-trucks-introduces-the-le-series-battery-electric-medium-duty-truck-at-act-expo-2026-302761451.html

SOURCE Hino Trucks

MEMPHIS, Tenn., May 4, 2026 /PRNewswire/ — Sedgwick, the world’s leading risk and claims administration partner, announced that Suzanne Dann has been appointed as Group President. As Group President, Dann will oversee Sedgwick’s major business lines globally, including casualty, property Americas, workforce absence and international operations.

This role strengthens Sedgwick’s operating model by unifying its core business lines under a single global leader, while enabling functional leaders to further scale enterprise capabilities and impact across markets.

“This appointment reflects our continued focus on strengthening how we operate, scale, and deliver for clients around the world,” said Mike Arbour, CEO, Sedgwick. “Suzanne’s experience and leadership will be instrumental as we continue to evolve our global platform and execute our long‑term strategy.”

Dann joins Sedgwick from Wipro, where she served as CEO of the Americas, leading one of the company’s largest and most strategically significant regions. Prior to Wipro, she held senior leadership roles at Avanade, an Accenture and Microsoft venture and IBM, where she developed deep expertise across technology, consulting and enterprise services.

Throughout her career, Dann has been recognized for building and scaling high performing teams, strengthening C-suite client relationships, and driving go‑to‑market strategies that align technology, risk management, and business outcomes. Dann brings deep experience in financial services and has overseen complex global operations and teams of more than 50,000 colleagues, delivering growth and strong margin performance.

“I am joining Sedgwick at a pivotal moment for the organization and the industry,” said Dann. “Sedgwick plays a critical role in helping clients navigate complexity and risk, and I look forward to working with the leadership team and colleagues around the world to build on that foundation, strengthen our operating model, leverage technology and continue delivering meaningful outcomes for colleagues and our clients.”

Dann holds a B.S. in Engineering from Cornell University and is a Certified Information Security Services Professional (CISSP).

Sedgwick continues to invest in leadership and operational capabilities that support its global growth strategy and commitment to service excellence across markets.

About Sedgwick
Sedgwick is the world’s leading risk and claims administration partner, helping clients thrive by navigating the unexpected. The company’s expertise, combined with the most advanced AI-enabled technology available, sets the standard for solutions in claims administration, loss adjusting, benefits administration and product recall. With over 33,000 colleagues and 10,000 clients across 80 countries, Sedgwick provides unmatched perspective, caring that counts, and solutions for the rapidly changing and complex risk landscape. Sedgwick’s majority shareholder is The Carlyle Group; Stone Point Capital LLC, Altas Partners, CDPQ, Onex and other management investors are minority shareholders. For more, see sedgwick.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/sedgwick-appoints-suzanne-dann-as-group-president-302760048.html

SOURCE Sedgwick Claims Management Services, Inc.